Patents by Inventor Huanlong Qin

Huanlong Qin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240139228
    Abstract: A pharmaceutical composition, comprises micro RNAs with or without chemical modification, and a carder suitable for delivery in vivo, the carrier is a branched histidine-lysine polypeptide or modified compound thereof. The pharmaceutical composition is capable of inhibiting the growth of colon cancer by inducing programmed death of cancer cell and further be used for the manufacture of a targeted drug for colorectal cancer treatment.
    Type: Application
    Filed: October 10, 2023
    Publication date: May 2, 2024
    Inventors: Alan Y. LU, Huanlong QIN, Menghan LIU, Patrick Y. LU
  • Publication number: 20180369273
    Abstract: A pharmaceutical composition, comprises micro RNAs with or without chemical modification, and a carrier suitable for delivery in vivo, the carrier is a branched histidine-lysine polypeptide or modified compound thereof. The pharmaceutical composition is capable of inhibiting the growth of colon cancer by inducing programmed death of cancer cell and further be used for the manufacture of a targeted drug for colorectal cancer treatment.
    Type: Application
    Filed: June 13, 2016
    Publication date: December 27, 2018
    Inventors: Alan Y. Lu, Huanlong Qin, Menghan Liu, Patrick Y Lu